Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene

Carcinogenesis

Volumn 19, Issue 6, 1998, Pages 1045-1052

  Gressani, Kiersten M ^a   Rollins, Lisa A ^a   Leone Kabler, Sandra ^a   Cline, J Mark ^a   Miller, Mark Steven ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CYTOCHROME P450 ISOENZYME; OLIGONUCLEOTIDE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL MUTAGENESIS; GENE AMPLIFICATION; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER SARCOMA; MOUSE; NONHUMAN; ONCOGENE C JUN; ONCOGENE H RAS; ONCOGENE RAS; PHARMACOGENETICS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSPLACENTAL CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; FEMALE; GENES, RAS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATERNAL-FETAL EXCHANGE; METHYLCHOLANTHRENE; MICE; MODELS, BIOLOGICAL; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0031878943     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.6.1045     Document Type: Article

References (57)

1. Rice,J.M. (1979) Perinatal period and pregnancy: intervals of high risk for chemical carcinogens. Environ. Health Perspect., 29, 23-27.
2. Miller,M.S., Jones,A.B. and Anderson,L.M. (1990) The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome P4501A1 by the carcinogen in fetal but not adult mice. Toxicol. Appl. Pharmacol., 104, 235-245.
3. Miller,M.S., Jones,A., Chauhan,D.P. and Anderson,L.M. (1990) Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetuses. Carcinogenesis, 11, 1979-1984.
4. Miller,M.S. (1994) Transplacental lung carcinogenesis: a pharmacogenetic mouse model for the modulatory role of cytochrome P4501A1 on lung cancer. Chem. Rex. Toxicol., 7, 471-481.
5. Sandler,D.P., Everson,R.B., Wilcox,A.J. and Browder,J.P. (1985) Cancer risk in adulthood from early life exposure to parents' smoking. Am. J. Public Health, 75, 487-492.
6. Stjernfeldt,M., Berglund,K., Lindsten,J. and Ludvigsson,J. (1986) Maternal smoking during pregnancy and risk of childhood cancer. Lancer, 1. 1350-1352.
7. John,E.M., Savitz,D.A. and Sandler,D.P. (1991) Prenatal exposure to parents' smoking and childhood cancer. Am. J. Epid., 133, 123-132.
8. Christianson,R.E. (1979) Gross differences observed in the placentas of smokers and nonsmokers. Am. J. Epid., 110, 178-187.
9. Miller,M.S., Jones,A.B., Chauhan,D., Park,S.S. and Anderson,L.M. (1989) Differential induction of fetal mouse liver and lung cytochromes P-450 by β-naphthoflavon and 3-methylcholanthrene. Carcinogenesis, 10, 875-883.
10. Kouri,R.E., McKinney,C.E., Slomiany,D.J., Snodgrass,D.R., Wray,N.P. and McLemore,T.L. (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res., 42, 5030-5037.
11. Hatch,M.C., Warburton,D. and Santella,R.M. (1990) Polycyclic aromatic hydrocarbon-DNA adducts in spontaneously aborted fetal tissue. Carcinogenesis, 11, 1673-1675.
12. Hansen,C., Sorensen,L.D., Asmussen,I. and Autrup,H. (1992) Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratogenesis, Carcinogenesis, Mutagenesis, 12, 51-60.
13. Manchester,D.K., Bowman,E.D., Parker,N.B., Caporaso,N.E and Weston,A. (1992) Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Cancer Res., 52, 1499-1503.
14. Mohr,U., Emura,M. and Richter-Reichelm,H.-B. (1980) Transplacental carcinogenesis. Invest. Cell. Pathol., 3, 209-229.
15. Anderson,L.M., Jones,A.B., Miller,M.S. and Chauhan,D.P. (1989) Metabolism of transplacental carcinogens. In Napalkov,N.R. Rice,J.M., Tomatis,L. and Yamasaki,H. (eds) Perinatal and Multigeneration Carcinogenesis. IARC Scientific Publications, Lyon, France, pp. 155-188.
16. Tomatis,L., Turusov,V., Guibbert,D., Duperray,B., Malaveille,C. and Pacheco,H. (1971) Transplacental carcinogenic effect of 3-methylcholanthrene in mice and its quantitation in fetal tissues. J. Natl Cancer Inst., 41, 645-651.
17. Wessner,L.L., Fan,M., Schaeffer,D.O., McEntee,M.F. and Miller,M.S. (1996) Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis, 17, 1519-1526.
18. Vogelstein,B. and Kinzler,K.W. (1993) The multistep nature of cancer. Trends Genet., 9, 138-141.
19. Sherr,C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
20. Bos,J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
21. Bishop,M.J. (1991) Molecular themes in oncogenesis. Cell, 64, 235-248.
22. Levine,A.J. (1993) The tumor suppressor genes. Annu. Rev. Biochem., 62, 623-651.
23. Rodenhuis,S. (1992) ras and human tumors. Semin. Cancer Biol., 3, 241-247.
24. Lane,D.P. (1992) Cancer. p53, guardian of the genome. Nature, 358, 15-16.
25. Levine,A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
26. Greenblatt,M.S., Bennett,W.P. Hollstein,M. and Harris,C.G. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
27. Selivanova,G. and Wiman,K.G. (1995) p53: a cell cycle regulator activated by DNA damage. Adv. Cancer Res., 66, 143-179.
28. Serrano,M. Lee,H-W., Chin,L., Cordon-Cardo,C. and Beach,D. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85, 27-37.
29. Weinberg,R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
30. Anderson,L.M., Jones,A.B., Riggs,C.W. and Ohshima,M. (1985) Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis, 6, 1389-1393.
31. Grisham,J.W. (1996) Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. Carcinogenesis, 18, 59-81.
32. Frith,C.H., Ward,J.M. and Turusov,V.S. (1990) Tumours of the liver. In Turusov,V. and Mohr,U. (eds) Pathology of Tumours in Laboratory Animals. IARC Scientific Publications, Lyon, France, pp. 223-269.
33. Wright,D.K. and Manos,M.M. (1990) Sample preparation from paraffin-embedded tissues. In Innis,M.A., Gelfand,D.H., Sninsky,J.J. and White,T.J. (eds) PCR Protocols: A Guide to Methods and Applications. Academic Press, Inc., San Diego, pp. 153-158.
34. Miller,M.S., Baxter,J.L., Moore,J.W., Lewis,J.D. and Schuller,H.M. (1994) Molecular characterization of neuroendocrine lung tumors induced in hamsters by treatment with nitrosamines and hyperoxia. Int. J. Oncol., 4, 5-12.
35. MacDonald,R.J., Swift,G.H., Przybyla,A.E. and Chirgwin,J.M. (1987) Isolation of RNA using guanidinium salts. Methods Enzymol., 152, 219-227.
36. Angel,P., Allegretto,E.A., Okino,S.T., Hattori,K., Boyle,W.J., Hunter,T. and Karin,M. (1988) Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature, 332, 166-171.
37. Stanton,L.W., Rosemary, W. and Marcu,K.B. (1983) Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature, 303, 401-406.
38. Curran,T., Peters,G., van Beveren,C., Teich,N.M. and Verma,I.M. (1982) FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol., 44, 674-682.
39. Xiong,Y., Connolly,T., Futcher,B. and Beach,D. (1991) Human D-type cyclin. Cell, 65, 691-699.
40. Koff,A., Cross,F., Fisher,A., Schumacher,J., Legueliec,K., Phillippe,M. and Roberts,J.M. (1991) Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell, 66, 1217-1228.
41. Harper,J.W., Adami,G.R., Wei,N., Keyomarsi,K. and Elledge,S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
42. Baker,S., Markowitz,S., Fearon,E.R., Willson,J.K.V. and Vogelstein,B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915.
43. Tso,J.Y., Sun,X-H., Kao,T., Reece,K.S. and Wu,R. (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res., 13, 2485-2502
44. Leone-Kabler,S., Wessner,L.L., McEntee,M.F., D'Agostino,R.B.,Jr and Miller,M.S. (1997) Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis, 18, 1163-1168.
45. Barbacid,M. (1987) ras genes. Annu. Rev. Biochem., 56, 779-827.
46. Zachos,G. and Spandidos,D.A. (1997) Expression of ras proto-oncogenes: regulation and implications in the development of human tumors. Crit. Rev. Oncol./Hematol., 26, 65-75.
47. Osborne,M.R., Brookes,P. Lee,H. and Harvey,R.G. (1986) The reaction of a 3-methylcholanthrene diol epoxide with DNA in relation to the binding of 3-methylcholanthrene to the DNA of mammalian cells. Carcinogenesis, 7, 1345-1350.
48. INK4b genes. Oncogene, 11, 635-645.
49. Herzog,C.R. and You,M. (1997) Sequence variation and chromosomal mapping of the murine cdkn2a tumor suppressor gene. Mamm. Genome, 8, 65-66.
50. Balmain,A., Ramsden,M., Bowden,G.T. and Smith,J. (1984) Activation of mouse cellular Harvey ras gene in chemically-induced benign skin papillomas. Nature (Lond), 307, 658-660.
51. Kumar,R., Sukumar,S. and Barbacid,M. (1990) Activation of ras oncogenes preceding the onset of neoplasia. Science, 248, 1101-1104.
52. Jones,P.A. (1996) DNA methylation errors and cancer. Cancer Res., 56, 2463-2467.
53. Fan,J. and Bertino,J.R. (1997) K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene, 14, 2595-2607.
54. INK4a. Cell, 88, 593-602.
55. Rollins,L.A., Leone-Kabler,S., O'Sullivan,M.G. and Miller,M.S. (1998) Role of tumor suppressor genes in transplacental lung carcinogenesis. Mol. Carcinogenesis, 21, 177-184.
56. Cha,R.S., Thilly,W.G. and Zarbl,H. (1994) N-Nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutation. Proc. Natl Acad. Sci. USA, 91, 3749-3753.
57. Donehower,L.A., Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery, C.A., Butel,J.S. and Bradley,A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.